Old Web
English
Sign In
Acemap
>
authorDetail
>
Arie Barlev
Arie Barlev
Medivation
Medicine
Enzalutamide
Internal medicine
Oncology
Pathology
5
Papers
22
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Treatment patterns and associated adverse events among patients with metastatic triple-negative breast cancer.
2017
Journal of Clinical Oncology
Virginia G. Kaklamani
Neil M. Schultz
Debra E. Irwin
Nicole Fulcher
Virginia Noxon
Jun Wu
Bhavik J. Pandya
Ruth Kim
Arie Barlev
Scott C. Flanders
Show All
Source
Cite
Save
Citations (2)
Hospital admissions (HA) among chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC) patients newly treated with enzalutamide (ENZA) or abiraterone (ABI).
2017
Journal of Clinical Oncology
Ruben G.W. Quek
Adrienne M. Gilligan
Shia T. Kent
Christopher Gregory
Neil M. Schultz
Scott C. Flanders
Bruce Brown
Elaine Karol Wong
Arie Barlev
Show All
Source
Cite
Save
Citations (2)
Sequencing in metastatic castrate-resistant prostate cancer with enzalutamide in a post-chemotherapy setting.
2016
Journal of Clinical Oncology
Ba Feinberg
Bhavik J. Pandya
Janna Radtchenko
David Garofalo
Scott Flanders
Bruce Brown
Arie Barlev
Menaka Bhor
Show All
Source
Cite
Save
Citations (0)
1